Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

Mutations in the LSS gene cause a rare type of hereditary hair loss.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

The document concludes that supportive home environments and addressing parent-child interactions can effectively treat trichotillomania in children.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The document concludes that correcting poor hair transplants requires a careful plan and a mix of techniques to achieve a natural look and address various challenges.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Vitiligo causes white skin patches and can lead to psychological stress.

Stingless bee propolis may help regenerate hair follicles and improve pigment function in chemotherapy-induced hair loss.

A Brazilian male with IFAP syndrome has a unique genetic variant causing his condition.

Diabetic patients often have ingrown nails due to obesity, high blood pressure, past injuries, bad nail trimming, nail fungus, weak foot pulse, and weak knee reflex.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

Babies born after 38 weeks to mothers under 36 years old and not delivered by C-section have a higher risk of neonatal occipital alopecia.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

The study concluded that patients with total hair loss and recurring hair loss had an earlier onset, longer-lasting condition, and a greater negative impact on their quality of life, with allergic conditions linked to more severe hair loss.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Restoring EDA and WNT pathways early may help improve skin, hair, and teeth issues in hypohidrotic ectodermal dysplasia.

Frontal fibrosing alopecia significantly affects men, often causing hair loss in eyebrows, beard, and sideburns.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

A specific gene mutation causes sparse, brittle hair in a family.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

The gene for Marie Unna hereditary hypotrichosis is located on chromosome 8p21.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.